<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.cpcancer.com/?rss=yes"><title>Current Problems in Cancer</title><description>Current Problems in Cancer RSS feed: Current Issue. Each bimonthly issue of  Current Problems in Cancer  presents a single-topic, in-depth discussion, usually focused on the integrated 
management of a particular type of cancer or on a problem faced in a wide variety of malignancies. Issues may explore a particular category 
of drugs, an emerging interventional technique, or rehabilitation/reconstruction. Extensive bibliographies allow readers to easily locate 
additional information on related topics.  Current Problems in Cancer  serves the wide spectrum of physicians who treat patients 
with neoplastic disease.


 
 
 2010 Topics , Volume 34, Issues 1-6 
 
 January 
Merkel Cell Carcinoma


   

     
 

 March  
Hepatocellular Carcinoma

	 
 
 
 May  
American College of Radiology Appropriateness Criteria

  
   
 
 July 

Proton Therapy

	  

  
 
  September Thymic Neoplasms

 	   
 
 November Combined Modality Therapy for Midface Lesions	


 
</description><link>http://www.cpcancer.com/?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2009 Published by Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>Current Problems in Cancer</prism:publicationName><prism:issn>0147-0272</prism:issn><prism:volume>33</prism:volume><prism:number>6</prism:number><prism:publicationDate>November 2009</prism:publicationDate><prism:copyright> © 2009 Published by Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.cpcancer.com/article/PIIS0147027210000048/abstract?rss=yes"/><rdf:li rdf:resource="http://www.cpcancer.com/article/PIIS014702721000005X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.cpcancer.com/article/PIIS0147027210000061/abstract?rss=yes"/><rdf:li rdf:resource="http://www.cpcancer.com/article/PIIS0147027210000073/abstract?rss=yes"/><rdf:li rdf:resource="http://www.cpcancer.com/article/PIIS0147027209000695/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.cpcancer.com/article/PIIS0147027210000048/abstract?rss=yes"><title>Title Page</title><link>http://www.cpcancer.com/article/PIIS0147027210000048/abstract?rss=yes</link><description></description><dc:title>Title Page</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S0147-0272(10)00004-8</dc:identifier><dc:source>Current Problems in Cancer 33, 6 (2009)</dc:source><dc:date>2009-11-01</dc:date><prism:publicationName>Current Problems in Cancer</prism:publicationName><prism:publicationDate>2009-11-01</prism:publicationDate><prism:volume>33</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0147-0272(10)X0002-2</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>327</prism:startingPage><prism:endingPage>327</prism:endingPage></item><item rdf:about="http://www.cpcancer.com/article/PIIS014702721000005X/abstract?rss=yes"><title>Information for Readers</title><link>http://www.cpcancer.com/article/PIIS014702721000005X/abstract?rss=yes</link><description></description><dc:title>Information for Readers</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S0147-0272(10)00005-X</dc:identifier><dc:source>Current Problems in Cancer 33, 6 (2009)</dc:source><dc:date>2009-11-01</dc:date><prism:publicationName>Current Problems in Cancer</prism:publicationName><prism:publicationDate>2009-11-01</prism:publicationDate><prism:volume>33</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0147-0272(10)X0002-2</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>328</prism:startingPage><prism:endingPage>328</prism:endingPage></item><item rdf:about="http://www.cpcancer.com/article/PIIS0147027210000061/abstract?rss=yes"><title>Table of Contents</title><link>http://www.cpcancer.com/article/PIIS0147027210000061/abstract?rss=yes</link><description></description><dc:title>Table of Contents</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S0147-0272(10)00006-1</dc:identifier><dc:source>Current Problems in Cancer 33, 6 (2009)</dc:source><dc:date>2009-11-01</dc:date><prism:publicationName>Current Problems in Cancer</prism:publicationName><prism:publicationDate>2009-11-01</prism:publicationDate><prism:volume>33</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0147-0272(10)X0002-2</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>329</prism:startingPage><prism:endingPage>330</prism:endingPage></item><item rdf:about="http://www.cpcancer.com/article/PIIS0147027210000073/abstract?rss=yes"><title>Author Bio Sketch</title><link>http://www.cpcancer.com/article/PIIS0147027210000073/abstract?rss=yes</link><description></description><dc:title>Author Bio Sketch</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S0147-0272(10)00007-3</dc:identifier><dc:source>Current Problems in Cancer 33, 6 (2009)</dc:source><dc:date>2009-11-01</dc:date><prism:publicationName>Current Problems in Cancer</prism:publicationName><prism:publicationDate>2009-11-01</prism:publicationDate><prism:volume>33</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0147-0272(10)X0002-2</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>331</prism:startingPage><prism:endingPage>332</prism:endingPage></item><item rdf:about="http://www.cpcancer.com/article/PIIS0147027209000695/abstract?rss=yes"><title>Neuroblastoma</title><link>http://www.cpcancer.com/article/PIIS0147027209000695/abstract?rss=yes</link><description>Neuroblastoma (NB) is the most common extracranial solid tumor of childhood and the most common tumor in infants. Over the last 2 decades, a tremendous amount of progress has been made in the understanding of NB biology; however, there are multiple challenges remaining so that we can successfully combat this disease. NB remains one of the most enigmatic pediatric tumors, displaying a wide variety of clinical behavior from spontaneous regression and differentiation to very aggressive behavior with rapid growth and spread. This article is aimed at providing a systematic review of NB: outlining disease characteristics, highlighting current treatment strategies and challenges, and providing potential areas of direction that may yield further improvement in the outcome of these patients.</description><dc:title>Neuroblastoma</dc:title><dc:creator>Natia Esiashvili, Cynthia Anderson, Howard M. Katzenstein</dc:creator><dc:identifier>10.1016/j.currproblcancer.2009.12.001</dc:identifier><dc:source>Current Problems in Cancer 33, 6 (2009)</dc:source><dc:date>2009-11-01</dc:date><prism:publicationName>Current Problems in Cancer</prism:publicationName><prism:publicationDate>2009-11-01</prism:publicationDate><prism:volume>33</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0147-0272(10)X0002-2</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>333</prism:startingPage><prism:endingPage>360</prism:endingPage></item></rdf:RDF>